Skip to content

Economic Evaluation of an Education Platform for Patients With End-stage Renal Disease

Economic Evaluation of an Interactive Community-based Patient Education Platform Kidney Dialysis and Transplantation

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03090828
Acronym
PIC-R
Enrollment
1600
Registered
2017-03-27
Start date
2017-09-30
Completion date
2022-03-31
Last updated
2017-03-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dialysis, End-stage Renal Disease, Kidney Transplantation

Keywords

economic evaluation, e health

Brief summary

1600 patients with severe, end stage renal disease or post transplant will be randomised 1:1:1 to either standard therapeutic education; or education using a specific app; or the enhanced interactive app using feedback messages. The total follow up duration is 18 months. Primary endpoint is the cost utility of using app-based therapeutic intervention, secondary endpoints are: compliance with treatment guidelines, app use (professionals and patients), budget impact analysis

Interventions

BEHAVIORALapp-based therapeutic education

Patients will connect to a platform providing information on end-stage renal disease and to contact health care providers.

BEHAVIORALenhanced app-based therapeutic education

Patients in the enhanced app group will also have access to a social network. (forum, chat room)

Sponsors

Centre Leon Berard
CollaboratorOTHER
Université Montpellier
CollaboratorOTHER
Telecom Bretagne
CollaboratorUNKNOWN
Paris School of Economics
CollaboratorUNKNOWN
Ministry of Health, France
CollaboratorOTHER_GOV
Assistance Publique - Hôpitaux de Paris
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* severe end-stage renal disease Internet, literacy informed consent

Exclusion criteria

* did not fill the screening questionnaire

Design outcomes

Primary

MeasureTime frameDescription
cost utility, efficiency, budget impact18 monthsincremental cost utility ratio

Secondary

MeasureTime frameDescription
compliance and persistence18 monthspercent of patients using the app at 18 months
disease knowledge18 monthsanswers to a questionnaire and change in the number of correct answers
overall survival18 monthspercent of patients alive at 18 months
app utilization by professionals and patients18 monthsnumber of connections, shares, likes
health care delivery organization18 monthsnumber of interactions (chats) between healthcare professionals and patients
lifestyle18 monthschanges in risk factors

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 10, 2026